Siponimod (Mayzent)--a new drug for multiple sclerosis.
Journal: 2019/June - Medical Letter on Drugs and Therapeutics
ISSN: 1523-2859
PUBMED: 31169805
Relations:
Citations
(1)
Diseases
(1)
Drugs
(5)
Chemicals
(1)
Processes
(2)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.